Table 1 Detectability of plasma marker concentrations
Classification | Plasma marker | Mean (pg/mL) + SE | LLD* (pg/mL) | below LLD (%) |
|---|---|---|---|---|
Apoptosis | Fas | 74 ± 3 | 1.3 | 0 |
|  | FasL | 68 ± 4 | 6.5 | 0 |
Acute phase | CRP | 6268332 ± 1124813 | 78 | 0 |
|  | MPO | 4381 ± 589 | 13 | 3 |
Chemokines | CCL2/MCP -1 | 202 ± 6 | 10 | 0 |
|  | CCL3/MIP-1α | 161 ± 33 | 6.8 | 5 |
|  | CCL4/MIP-1β | 115 ± 20 | 1.3 | 1 |
|  | CCL5/RANTES | 5249 ± 398 | 8.2 | 0 |
|  | CCL11/eotaxin | 76 ± 3 | 2.3 | 0 |
|  | CXCL8/IL-8 | 11 ± 0.4 | 6.1 | 0 |
|  | CXCL9/Mig | 1163 ± 87 | 35 | 0 |
T H Related Cytokines | IFN-γ | 55 ± 7 | 2.1 | 8 |
|  | IL-2 | 103 ± 23 | 2.6 | 23 |
|  | IL-2R†| 344 ± 28 | 39 | 0 |
|  | IL-4 | 15 ± 3 | 0.6 | 25 |
|  | IL-13 | 98 ± 7 | 8.2 | 11 |
Inflammation | TNF-α | 55 ± 7 | 5.3 | 0 |
|  | TNFRI†| 1352 ± 95 | 36 | 0 |
|  | TNFRII†| 3231 ± 138 | 39 | 0 |
|  | IL-1β | 72 ± 17 | 8.5 | 45 |
|  | IL-6 | 19 ± 4 | 0.4 | 1 |
|  | IL-10 | 0.3 ± 0.08 | 0.2 | 96 |
Growth Factors | EGF | 19 ± 1.5 | 2.5 | 0 |
|  | EGFR†| 19769 ± 434 | 13.5 | 0 |
|  | FGFβ | NE‡ | NE‡ | NE‡ |
|  | G-CSF | 2496 ± 180 | 379 | 0 |
|  | HGF | 196 ± 9 | 2.8 | 0 |
|  | VEGF | NE‡ | NE‡ | NE‡ |